Literature DB >> 2861569

Pertussis toxin reverses adenosine inhibition of neuronal glutamate release.

A C Dolphin, S A Prestwich.   

Abstract

Adenosine and its analogues are potent inhibitors of synaptic activity in the central and peripheral nervous system. In the central nervous system (CNS), this appears to arise primarily by inhibition of presynaptic release of transmitters, including glutamate, which is possibly the major excitatory transmitter in the brain. In addition, postsynaptic effects of adenosine have been reported which would also serve to reduce neurotransmission. The mechanism by which adenosine inhibits CNS neurotransmission is unknown, although it appears to exert its effect via an A1 receptor which in some systems is negatively coupled to adenylate cyclase. In an attempt to elucidate the mechanism of inhibition, we have examined the effect of pertussis toxin (PTX) on the ability of the stable adenosine analogue (-)phenylisopropyladenosine (PIA) to inhibit glutamate release from cerebellar neurones maintained in primary culture. PTX, by ADP-ribosylating the nucleotide-binding protein Ni, prevents coupling of inhibitory receptors such as the A1 receptor to adenylate cyclase. As reported here, we found that PTX, as well as preventing inhibition of adenylate cyclase by PIA, also converts the PIA-induced inhibition of glutamate release to a stimulation. Our results suggest strongly that purinergic inhibitory modulation of transmitter release occurs by inhibition of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861569     DOI: 10.1038/316148a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  39 in total

1.  Adenosine inhibition via A(1) receptor of N-type Ca(2+) current and peptide release from isolated neurohypophysial terminals of the rat.

Authors:  Gang Wang; Govindan Dayanithi; Edward E Custer; José R Lemos
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

Review 2.  Neuropharmacologic targets and agents in fibromyalgia.

Authors:  Rie Suzuki; Anthony H Dickenson
Journal:  Curr Pain Headache Rep       Date:  2002-08

3.  Pertussis toxin-sensitive GTP-binding proteins characterized in synaptosomal fractions of embryonic avian cerebral cortex.

Authors:  G G Holz; T J Turner
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1998-01       Impact factor: 2.231

4.  How Postdoctoral Research in Paul Greengard's Laboratory Shaped My Scientific Career, Although I Never Did Another Phosphorylation Assay.

Authors:  Annette C Dolphin
Journal:  J Neurosci       Date:  2021-02-08       Impact factor: 6.167

5.  Analysis of adenosine actions on Ca2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurones.

Authors:  K P Scholz; R J Miller
Journal:  J Physiol       Date:  1991-04       Impact factor: 5.182

6.  Role of pertussis toxin-sensitive G-protein, K+ channels, and voltage-gated Ca2+ channels in the antinociceptive effect of inosine.

Authors:  Sérgio José Macedo-Junior; Francisney Pinto Nascimento; Murilo Luiz-Cerutti; Adair Roberto Soares Santos
Journal:  Purinergic Signal       Date:  2012-07-18       Impact factor: 3.765

7.  The effect of reduced temperature on the inhibitory action of adenosine and magnesium ion at frog motor nerve terminals.

Authors:  E M Silinsky; J K Hirsh
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

8.  Pertussis toxin is required for pertussis vaccine encephalopathy.

Authors:  L Steinman; A Weiss; N Adelman; M Lim; R Zuniga; J Oehlert; E Hewlett; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Pertussis toxin does not affect the adenosine-induced inhibition of the efferent function of cardiac capsaicin-sensitive nerves.

Authors:  L Mantelli; S Amerini; A Rubino; F Ledda
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Pertussis toxin prevents the inhibitory effect of adenosine and unmasks adenosine-induced excitation of mammalian motor nerve endings.

Authors:  E M Silinsky; C Solsona; J K Hirsh
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.